Checkpoint Therapeutics Inc (CKPT)
3.75
+0.28
(+8.07%)
USD |
NASDAQ |
Nov 22, 16:00
3.72
-0.03
(-0.80%)
After-Hours: 20:00
Checkpoint Therapeutics Total Assets (Quarterly): 5.179M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.179M |
| June 30, 2024 | 5.67M |
| March 31, 2024 | 11.98M |
| December 31, 2023 | 5.378M |
| September 30, 2023 | 2.218M |
| June 30, 2023 | 8.338M |
| March 31, 2023 | 5.896M |
| December 31, 2022 | 13.29M |
| September 30, 2022 | 21.62M |
| June 30, 2022 | 32.08M |
| March 31, 2022 | 42.91M |
| December 31, 2021 | 55.73M |
| September 30, 2021 | 60.97M |
| June 30, 2021 | 66.12M |
| March 31, 2021 | 61.43M |
| December 31, 2020 | 42.60M |
| September 30, 2020 | 42.64M |
| Date | Value |
|---|---|
| June 30, 2020 | 22.68M |
| March 31, 2020 | 23.21M |
| December 31, 2019 | 26.97M |
| September 30, 2019 | 14.08M |
| June 30, 2019 | 15.22M |
| March 31, 2019 | 15.29M |
| December 31, 2018 | 24.90M |
| September 30, 2018 | 30.80M |
| June 30, 2018 | 28.96M |
| March 31, 2018 | 36.43M |
| December 31, 2017 | 21.41M |
| September 30, 2017 | 25.66M |
| June 30, 2017 | 28.94M |
| March 31, 2017 | 33.21M |
| December 31, 2016 | 35.98M |
| September 30, 2016 | 39.95M |
| December 31, 2015 | 50.65M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.218M
Minimum
Sep 2023
66.12M
Maximum
Jun 2021
27.85M
Average
22.95M
Median
Total Assets (Quarterly) Benchmarks
| Fortress Biotech Inc | 127.08M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 17.77M |
| Shareholders Equity (Quarterly) | -12.59M |